{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/HALO/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-23T01:26:35.942Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":2412,"canonical_name":"HALOZYME THERAPEUTICS, INC.","cik":"0001159036","uei":null,"lei":null,"duns":null,"ticker":"HALO"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":69},"count":69,"timeline":[{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":15492,"price_per_share":107.154,"usd_value":1660030,"security_title":"Common Stock","importance":36.660029768},{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":4508,"price_per_share":107.548,"usd_value":484826,"security_title":"Common Stock","importance":35.484826384},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — HALOZYME THERAPEUTICS, INC. — 2026-09-11","url_slug":"/sec/cik-0001159036/4/0001159036-26-000119","accession_number":"0001159036-26-000119","importance":30},{"ts":"2026-09-11","kind":"sec.insider.m","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":20000,"price_per_share":18.41,"usd_value":368200,"security_title":"Common Stock","importance":15.3682},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":14588,"price_per_share":107.012,"usd_value":1561091,"security_title":"Common Stock","importance":36.561091056},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":5412,"price_per_share":107.581,"usd_value":582228,"security_title":"Common Stock","importance":35.582228372},{"ts":"2026-09-10","kind":"sec.insider.m","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":20000,"price_per_share":18.41,"usd_value":368200,"security_title":"Common Stock","importance":15.3682},{"ts":"2026-09-09","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":13304,"price_per_share":107.222,"usd_value":1426481,"security_title":"Common Stock","importance":36.426481488},{"ts":"2026-09-09","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":6596,"price_per_share":107.821,"usd_value":711187,"security_title":"Common Stock","importance":35.711187316},{"ts":"2026-09-09","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":100,"price_per_share":108.67,"usd_value":10867,"security_title":"Common Stock","importance":35.010867},{"ts":"2026-09-09","kind":"sec.insider.m","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":20000,"price_per_share":18.41,"usd_value":368200,"security_title":"Common Stock","importance":15.3682},{"ts":"2026-08-11","kind":"sec.form144","reporter":"CORTNEY A CAUDILL","title":"Officer","shares":41702,"usd_value":4302349,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001950047-26-007986","importance":40.860469894},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — HALOZYME THERAPEUTICS, INC. — 2026-08-11","url_slug":"/sec/cik-0001159036/144/0001950047-26-007986","accession_number":"0001950047-26-007986","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"4","title":"4 — HALOZYME THERAPEUTICS, INC. — 2026-08-11","url_slug":"/sec/cik-0001159036/4/0001662521-26-000002","accession_number":"0001662521-26-000002","importance":30},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Connaughton Bernadette","title":null,"shares":1626,"price_per_share":102.8,"usd_value":167153,"security_title":"Common Stock","importance":35.1671528},{"ts":"2026-07-09","kind":"sec.filing","form_type":"4","title":"4 — HALOZYME THERAPEUTICS, INC. — 2026-07-09","url_slug":"/sec/cik-0001159036/4/0001159036-26-000100","accession_number":"0001159036-26-000100","importance":30},{"ts":"2026-07-08","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":1035,"price_per_share":80.187,"usd_value":82994,"security_title":"Common Stock","importance":35.082993545},{"ts":"2026-07-08","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":888,"price_per_share":79.276,"usd_value":70397,"security_title":"Common Stock","importance":35.070397088},{"ts":"2026-07-08","kind":"sec.insider.m","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":1923,"price_per_share":12.07,"usd_value":23211,"security_title":"Common Stock","importance":15.02321061},{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — HALOZYME THERAPEUTICS, INC. — 2026-07-02","url_slug":"/sec/cik-0001159036/8-k/0001159036-26-000088","accession_number":"0001159036-26-000088","importance":35},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — HALOZYME THERAPEUTICS, INC. — 2026-07-02","url_slug":"/sec/cik-0001159036/4/0001159036-26-000094","accession_number":"0001159036-26-000094","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — HALOZYME THERAPEUTICS, INC. — 2026-07-02","url_slug":"/sec/cik-0001159036/4/0001159036-26-000095","accession_number":"0001159036-26-000095","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — HALOZYME THERAPEUTICS, INC. — 2026-07-02","url_slug":"/sec/cik-0001159036/4/0001159036-26-000096","accession_number":"0001159036-26-000096","importance":30},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Connaughton Bernadette","title":null,"shares":1000,"price_per_share":76.395,"usd_value":76395,"security_title":"Common Stock","importance":35.076395},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Connaughton Bernadette","title":null,"shares":625,"price_per_share":77.209,"usd_value":48256,"security_title":"Common Stock","importance":35.048255625},{"ts":"2026-06-30","kind":"sec.insider.f","reporter":"RAMSAY DAVID A","title":"EVP, PRESIDENT, DRUG DELIVERY","shares":5408,"price_per_share":78.27,"usd_value":423284,"security_title":"Common Stock","importance":15.42328416},{"ts":"2026-06-30","kind":"sec.insider.m","reporter":"RAMSAY DAVID A","title":"EVP, PRESIDENT, DRUG DELIVERY","shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-29","kind":"sec.form144","reporter":"MAHESH KRISHNAN","title":"Director","shares":7304,"usd_value":547508,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001950047-26-006595","importance":40.109501568},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Krishnan Mahesh","title":null,"shares":7304,"price_per_share":75,"usd_value":547800,"security_title":"Common Stock","importance":35.5478},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — HALOZYME THERAPEUTICS, INC. — 2026-06-29","url_slug":"/sec/cik-0001159036/144/0001950047-26-006595","accession_number":"0001950047-26-006595","importance":30},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Krishnan Mahesh","title":null,"shares":7304,"price_per_share":38.46,"usd_value":280912,"security_title":"Common Stock","importance":15.28091184},{"ts":"2026-06-12","kind":"sec.insider.f","reporter":"Snyder Mark Howard","title":"SVP, CHIEF LEGAL OFFICER","shares":2715,"price_per_share":69.5,"usd_value":188693,"security_title":"Common Stock","importance":15.1886925},{"ts":"2026-06-12","kind":"sec.insider.m","reporter":"Snyder Mark Howard","title":"SVP, CHIEF LEGAL OFFICER","shares":5034,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-09","kind":"sec.filing","form_type":"3","title":"3 — HALOZYME THERAPEUTICS, INC. — 2026-06-09","url_slug":"/sec/cik-0001159036/3/0001159036-26-000076","accession_number":"0001159036-26-000076","importance":30},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":6100,"price_per_share":69.692,"usd_value":425121,"security_title":"Common Stock","importance":35.4251212},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":2000,"price_per_share":68.736,"usd_value":137472,"security_title":"Common Stock","importance":35.137472},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":1500,"price_per_share":67.675,"usd_value":101513,"security_title":"Common Stock","importance":35.1015125},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":400,"price_per_share":66.368,"usd_value":26547,"security_title":"Common Stock","importance":35.0265472},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — HALOZYME THERAPEUTICS, INC. — 2026-06-03","url_slug":"/sec/cik-0001159036/4/0001159036-26-000074","accession_number":"0001159036-26-000074","importance":30},{"ts":"2026-06-03","kind":"sec.insider.m","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":10000,"price_per_share":12.07,"usd_value":120700,"security_title":"Common Stock","importance":15.1207},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":16600,"price_per_share":66.314,"usd_value":1100812,"security_title":"Common Stock","importance":36.1008124},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":3400,"price_per_share":66.745,"usd_value":226933,"security_title":"Common Stock","importance":35.226933},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — HALOZYME THERAPEUTICS, INC. — 2026-06-02","url_slug":"/sec/cik-0001159036/4/0001159036-26-000072","accession_number":"0001159036-26-000072","importance":30},{"ts":"2026-06-02","kind":"sec.insider.m","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":20000,"price_per_share":12.07,"usd_value":241400,"security_title":"Common Stock","importance":15.2414},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":12989,"price_per_share":67.41,"usd_value":875588,"security_title":"Common Stock","importance":35.87558849},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":5401,"price_per_share":68.346,"usd_value":369137,"security_title":"Common Stock","importance":35.369136746},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Connaughton Bernadette","title":null,"shares":1625,"price_per_share":66.21,"usd_value":107591,"security_title":"Common Stock","importance":35.10759125},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":1610,"price_per_share":66.388,"usd_value":106885,"security_title":"Common Stock","importance":35.10688468},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":20000,"price_per_share":12.07,"usd_value":241400,"security_title":"Common Stock","importance":15.2414},{"ts":"2026-05-15","kind":"sec.filing","form_type":"144","title":"144 — HALOZYME THERAPEUTICS, INC. — 2026-05-15","url_slug":"/sec/cik-0001159036/144/0001950047-26-004590","accession_number":"0001950047-26-004590","importance":30},{"ts":"2026-05-13","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":3950,"price_per_share":69.787,"usd_value":275659,"security_title":"Common Stock","importance":35.27565865},{"ts":"2026-05-13","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":3350,"price_per_share":68.88,"usd_value":230748,"security_title":"Common Stock","importance":35.230748},{"ts":"2026-05-13","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":2100,"price_per_share":68.102,"usd_value":143014,"security_title":"Common Stock","importance":35.1430142},{"ts":"2026-05-13","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":600,"price_per_share":70.812,"usd_value":42487,"security_title":"Common Stock","importance":35.0424872},{"ts":"2026-05-13","kind":"sec.filing","form_type":"4","title":"4 — HALOZYME THERAPEUTICS, INC. — 2026-05-13","url_slug":"/sec/cik-0001159036/4/0001159036-26-000070","accession_number":"0001159036-26-000070","importance":30},{"ts":"2026-05-13","kind":"sec.insider.m","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":10000,"price_per_share":12.07,"usd_value":120700,"security_title":"Common Stock","importance":15.1207},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":9802,"price_per_share":71.37,"usd_value":699569,"security_title":"Common Stock","importance":35.69956874},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":5900,"price_per_share":72.148,"usd_value":425673,"security_title":"Common Stock","importance":35.4256732},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":2800,"price_per_share":73.121,"usd_value":204739,"security_title":"Common Stock","importance":35.2047388},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":1398,"price_per_share":70.287,"usd_value":98261,"security_title":"Common Stock","importance":35.098261226},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":100,"price_per_share":67.85,"usd_value":6785,"security_title":"Common Stock","importance":35.006785},{"ts":"2026-05-12","kind":"sec.insider.m","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":20000,"price_per_share":12.07,"usd_value":241400,"security_title":"Common Stock","importance":15.2414},{"ts":"2026-05-11","kind":"sec.filing","form_type":"10-Q","title":"10-Q — HALOZYME THERAPEUTICS, INC. — 2026-05-11","url_slug":"/sec/cik-0001159036/10-q/0001159036-26-000068","accession_number":"0001159036-26-000068","importance":45},{"ts":"2026-05-11","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":9725,"price_per_share":64.631,"usd_value":628536,"security_title":"Common Stock","importance":35.628536475},{"ts":"2026-05-11","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":6700,"price_per_share":66.327,"usd_value":444391,"security_title":"Common Stock","importance":35.4443909},{"ts":"2026-05-11","kind":"sec.insider.s","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":3575,"price_per_share":65.458,"usd_value":234012,"security_title":"Common Stock","importance":35.23401235},{"ts":"2026-05-11","kind":"sec.filing","form_type":"8-K","title":"8-K — HALOZYME THERAPEUTICS, INC. — 2026-05-11","url_slug":"/sec/cik-0001159036/8-k/0001159036-26-000067","accession_number":"0001159036-26-000067","importance":35},{"ts":"2026-05-11","kind":"sec.filing","form_type":"144","title":"144 — HALOZYME THERAPEUTICS, INC. — 2026-05-11","url_slug":"/sec/cik-0001159036/144/0001968582-26-000422","accession_number":"0001968582-26-000422","importance":30},{"ts":"2026-05-11","kind":"sec.insider.m","reporter":"Torley Helen","title":"PRESIDENT AND CEO","shares":20000,"price_per_share":12.07,"usd_value":241400,"security_title":"Common Stock","importance":15.2414}]}